About QOF
The indicators listed here have been developed through the NICE Indicator development process and have been deemed appropriate to be considered for inclusion in the QOF.
This NICE menu of QOF indicators is a full list of indicators that have been developed by NICE.
NHS England and the UK devolved administrations will use the NICE QOF menu to help decide which indicators are included in the QOF within their countries.
Atrial fibrillation
In those patients with atrial fibrillation with a record of a CHA2DS2-VASc score of 2 or more, the percentage of patients who are currently treated with anticoagulation drug therapy
The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring system in the preceding 12 months (excluding those patients with a previous CHADS2 or CHA2DS2-VASc score of 2 or more)
Blood pressure
The percentage of patients aged 40 years and over with a blood pressure measurement recorded in the preceding 5 years
Cancer
The percentage of patients with cancer diagnosed within the preceding 15 months who have a review recorded as occurring within 3 months of the practice receiving confirmation of the diagnosis
Cardiovascular disease – primary prevention
In those patients aged between 25 and 84 years, with a new diagnosis of hypertension or type 2 diabetes recorded in the preceding 12 months (excluding those with pre-existing cardiovascular disease, chronic kidney disease, familial hypercholesterolaemia or type 1 diabetes), who have a recorded cardiovascular risk assessment score of more than 20% in the preceding 12 months: the percentage who are currently treated with statins (unless there is a contraindication)
The percentage of patients aged between 25 and 84 years with a new diagnosis of hypertension or type 2 diabetes, recorded in the preceding 12 months (excluding those with pre-existing cardiovascular disease, chronic kidney disease, familial hypercholesterolaemia or type 1 diabetes) who have had a consultation for full formal cardiovascular disease risk assessment between 3 months before or 3 months after date of diagnosis.
Chronic kidney disease
The contractor establishes and maintains a register of patients aged 18 years or over with CKD with classification of categories G3a to G5 (previously stage 3 to 5)
The percentage of patients on the CKD register who have hypertension and proteinuria and who are currently being treated with an angiotensin-receptor blocker or an angiotensin-converting enzyme inhibitor
The percentage of patients on the CKD register whose notes have a record of a urine albumin:creatinine ratio (or protein:creatinine ratio) test in the preceding 12 months
Chronic obstructive pulmonary disease
The percentage of patients with COPD and Medical Research Council (MRC) Dyspnoea Scale of 3 or more at any time in the preceding 15 months, with a subsequent record of an offer of referral to a pulmonary rehabilitation programme
The percentage of patients with COPD who have had influenza immunisation in the preceding 1 August to 31 March
The percentage of patients with COPD with a record of FEV1 in the preceding 12 months
Contraception
The percentage of women, on the register, prescribed an oral or patch contraceptive method in the preceding 12 months who have also received information from the contractor about long acting reversible methods of contraception in the preceding 12 months
Coronary heart disease
The percentage of patients with coronary heart disease who have had influenza immunisation in the preceding 1 August to 31 March
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Dementia
The percentage of patients diagnosed with dementia whose care plan has been reviewed in a face-to-face review in the preceding 12 months
The percentage of patients with dementia with the contact details of a named carer on their record
Depression
The percentage of patients with a new diagnosis of depression in the preceding 1 April to 31 March who have been reviewed within 10-35 days of the date of diagnosis
The percentage of patients with a new diagnosis of depression in the preceding 1 April to 31 March who have had a bio-psychosocial assessment by the point of diagnosis
Diabetes mellitus
The contractor establishes and maintains a register of all patients aged 17 or over with diabetes mellitus, which specifies the type of diabetes where a diagnosis has been confirmed
The percentage of male patients with diabetes who have a record of erectile dysfunction with a record of advice and assessment of contributory factors and treatment options in the preceding 15 months
The percentage of male patients with diabetes with a record of being asked about erectile dysfunction in the preceding 15 months
The percentage of patients newly diagnosed with diabetes, on the register, in the preceding 1 April to 31 March who have a record of being referred to a structured education programme within 9 months after entry on to the diabetes register
The percentage of patients with diabetes who have a record of a dietary review by a suitably competent professional in the preceding 15 months
The percentage of patients with diabetes who have a record of an albumin:creatinine ratio (ACR) test in the preceding 15 months